Crohn's disease
Feedback

From WikiLectures

Revision as of 14:38, 10 December 2021 by Kuky36 (talk | contribs) (mistakes)

  • Crohn's disease (colitis regionalis, terminal ileitis) is a chronic inflammatory íntestinal disease
  • inflammation occurs in any part of the digestive tract and has a segmental character
    • there are sections of healthy mucosa between the affected areas.
  • the most commonly affected area is the terminal ileum
  • inflammation affects the entire wall thickness of the organ and is characterized by the presence of non-caseifying epithelioid granulomas.

Epidemiology

  • Crohn's disease is more common in younger people
  • the highest prevalence is in the group of 30-39 years. 10% of patients are diagnosed before the age of 17.
    • the average prevalence in adults is about 130 / 100,000, the incidence is 5.6 / 100,000 inhabitants; •
    • the incidence in children is on the rise, reaching up to 9-10 / 100,000, especially in northern Europe •
    • the incidence in children in the Czech Republic is 6.2 / 100,000.

Risk factors

  • • Grade 1 relatives have a 10-35-fold higher risk of disease. •
  • Genetic mutations. •
  • High hygienic standards in childhood, smoking, early appendectomy, and non-steroidal anti-inflammatory drugs.

Etiopathogenesis

  • The cause of the disease is not yet known
  • This is probably a dysregulation of the immune response to common bacterial antigens
  • During the autoimmune reaction, transmural inflammation occurs, that affects the entire wall of the intestine, which often passes to the mesentery.
  • Epithelioid granulomas, ulcerations, and fissures form in the intestinal wall.
  • We often see intramural and intraperitoneal abscesses or fistulas (especially in the anal area).
  • Due to long-term inflammation, the bowel may narrow by scarring of the tissue (scar stricture).
  • Crohn's disease is characterized by segmental GIT involvement → alternating inflammatory and unaffected sections ("skip lesions").
  • Predilection areas include the terminal ileum and ascending colon, but any part of the GIT can be affected.

Pathological picture

  • The entire intestinal wall is affected and the inflammation is segmental or plurisegmental.
  • Typically, the affected sections alternate with the unaffected sections (unlike ulcerative colitis).

Macroscopic image

  • Macroscopically, we see thickening of the intestinal wall and mesentery. Regional lymph nodes are often enlarged.
  • The mucosa is hypertrophic and edematous.
  • The image is often compared to cobblestones - elongated aphthous ulcers above the lymphatic follicles surrounding the unaffected mucosa, swollen fistula mouths, pseudopolyps.
  • Affected serosis leads to adhesions in which fistulas form. In the further course of the disease, fiber production follows, which leads to stenoses.

Microscopic image

  • In the microscope we see mucosal edema with polymorphonuclear infiltration, followed by fiber production with the formation of tuberculoid granulomas (epithelioid cells and giant Langhans-type cells, unlike TB, do not caseify) in the submucosa, subserous, and regional nodes.

Clinical picture

  • Like all autoimmune diseases, Crohn's disease manifests itself in multiple systems.
  • The typical manifestation is in the digestive tract, but the eyes, skin and mucous membranes, liver, pancreas, kidneys are also affected, and blood homeostasis is often disturbed.

Intestinal manifestations

  • Common symptoms include abdominal pain and chronic diarrhea (rarely with blood).
  • Fissures, perianal abscesses, fistulas, and mariske (anal lashes - skin growths in the area of the anus and skin transition) may occur around the rectum.

Extraintestinal manifestation

  • Extraintestinal symptoms occur in more than 40% of patients.
  • It often precedes intestinal manifestations by up to several years.
  • These are mostly non-specific symptoms such as recurrent fevers, anorexia, weight loss, and growth retardation, especially in children.
  • The main systems that tend to be affected include:
  1. skeleton: growth failure and osteoporosis (proinflammatory cytokines suppress growth, suppress IGF-1 production, stimulate bone resorption; insufficient energy intake, malabsorption, loss of protein and trace elements in the stool, chronic treatment with corticosteroids)
  2. skin and mucous membranes: aphthous stomatitis, gingivitis, granulomatosis cheilitis, erythema nodosum on the lower legs, and purulent pyoderma
  3. eyes: iritis, uveitis, episcleritis; rare in children; corticoid therapy can cause cataracts and glaucoma
  4. liver and pancreas: primary sclerosing cholangitis, cholecystolithiasis; pancreatitis after azathioprine or mesalazine therapy
  5. vascular system: hypercoagulable state (thrombocytosis, increased fibrin, factor V and VII, decreased antithrombin), which may cause deep vein thrombosis, pulmonary embolism or CMP
  6. kidneys and urinary tract: fistulas, urinary stones.

Complication

  • Inflammation often spreads to the surrounding area and forms fistulas (ie, canals connecting the sites of inflammation to any other site).
  • Fistulas can be:
  1. internal: enteroenteric, enterocolic, enterovesical, rectovaginal
  2. external (perineal abdominal wall)
  3. Other complications include
    • formation of abscesses, which may be intercostal, pelvic, retroperitoneal, hepatic
    • intestinal stenosis, which is dangerous due to the impending ileus
    • perianal fissures
    • intestinal perforation and its complications: peritonitis
    • massive bleeding
    • toxic megacolon
    • reversal in cancer